Published in BMJ on July 23, 1988
Mixed systemic amyloidosis in a patient receiving long term haemodialysis. J Clin Pathol (1994) 0.89
Beta 2 microglobulin haemodialysis related amyloidosis: distinctive gross features of gastrointestinal involvement. J Clin Pathol (1997) 0.80
Nephrology, dialysis and transplantation. Postgrad Med J (1993) 0.75
Amyloid arthropathy in patients undergoing periodical haemodialysis for chronic renal failure: a new complication. Ann Rheum Dis (1985) 1.93
A clinical analysis of the course and prognosis of forty-two patients with amyloidosis. Am J Med (1968) 1.80
Dialysis arthropathy: complication of long term treatment with haemodialysis. Br Med J (Clin Res Ed) (1986) 1.67
Dialysis-related amyloidosis. Nephrol Dial Transplant (1986) 1.23
Systemic amyloidosis of beta 2-microglobulin type: a complication of long-term haemodialysis. J Clin Pathol (1987) 1.21
Functional anatomy of the lymphocyte in immunological reactions in vitro. J Exp Med (1966) 2.91
A collaborative scheme for tissue typing and matching in renal transplantation. Lancet (1969) 2.26
Wegener's granulomatosis: observations on 18 patients with severe renal disease. Q J Med (1983) 2.07
Lipid nephrotoxicity in chronic progressive glomerular and tubulo-interstitial disease. Lancet (1982) 1.98
Factors affecting the reactivity of human lymphocytes in vitro. I. Cell number, duration of culture and surface area. J Immunol (1967) 1.96
Dysregulation of LDL receptor under the influence of inflammatory cytokines: a new pathway for foam cell formation. Kidney Int (2001) 1.71
Plasma-exchange and immunosuppression in the treatment of fulminating immune-complex crescentic nephritis. Lancet (1977) 1.71
Serum ferritin assay and iron status in chronic renal failure and haemodialysis. Br Med J (1975) 1.61
Epstein Barr virus nuclear antigen positive lymphoma after cyclosporin A treatment in patient with renal allograft. Lancet (1980) 1.60
Abdominal hernias in patients receiving continuous ambulatory peritoneal dialysis. Br Med J (Clin Res Ed) (1981) 1.59
Cancer in patients receiving dialysis. Br Med J (1980) 1.52
The polyneuropathy of chronic renal failure. Brain (1971) 1.49
Influence of HLA matching and blood-transfusion on outcome of 502 London Transplant Group renal-graft recipients. Lancet (1976) 1.47
Post-renal transplant distal limb bone pain. An under-recognized complication of transplantation distinct from avascular necrosis of bone? Transplantation (1995) 1.45
Review article: renal function assessment in cirrhosis - difficulties and alternative measurements. Aliment Pharmacol Ther (2007) 1.45
Symptomatic cytomegalovirus infection in seropositive kidney recipients: reinfection with donor virus rather than reactivation of recipient virus. Lancet (1988) 1.41
Low-dose vs high-dose intravenous methylprednisolone therapy for acute renal allograft rejection in patients receiving cyclosporin therapy. Nephrol Dial Transplant (1989) 1.39
Cyclosporin-induced renal magnesium leak in renal transplant patients. Nephrol Dial Transplant (1990) 1.38
Editorial: home dialysis or transplantation. Clin Nephrol (1974) 1.37
Influence of HL-A matching antigenic strength, and immune responsiveness on outcome of 349 cadaver renal grafts. 3 years' experience of the London transplant group. Lancet (1972) 1.36
Kinetics of cytomegalovirus load decrease in solid-organ transplant recipients after preemptive therapy with valganciclovir. J Infect Dis (2004) 1.35
Sixteen months experience with cyclosporin-A in human kidney transplantation. Transplant Proc (1981) 1.35
Atherosclerotic renovascular disease causing renal impairment--a case for treatment. Clin Nephrol (1989) 1.28
Longitudinal analysis of cytomegalovirus load in renal transplant recipients using a quantitative polymerase chain reaction: correlation with disease. J Gen Virol (1995) 1.26
Multicentre collaboration in 162 tissue-typed renal transplants. The London and Regional Transplant Group, March, 1969, to December, 1970. Lancet (1971) 1.25
Hepatitis-associated antigen and antibody in haemodialysis patients and staff. Br Med J (1970) 1.23
Rhabdomyolysis and systemic infection. Br Med J (Clin Res Ed) (1983) 1.22
Functional impairment of cytomegalovirus specific CD8 T cells predicts high-level replication after renal transplantation. Am J Transplant (2008) 1.19
Glycosylated haemoglobin in chronic renal failure. Br Med J (1979) 1.16
Lipid abnormalities in uremia, dialysis, and transplantation. Kidney Int (1981) 1.15
Quantity of cytomegalovirus viruria is a major risk factor for cytomegalovirus disease after renal transplantation. J Med Virol (1997) 1.15
Recurrent hyperinfestation with Strongyloides stercoralis in a renal allograft recipient. Br Med J (Clin Res Ed) (1982) 1.13
Atrial thrombus and central venous dialysis catheters. Am J Kidney Dis (2001) 1.11
Long-term T-cell-mediated immunity to Epstein-Barr virus in renal-allograft recipients receiving cyclosporin A. Lancet (1981) 1.11
Lymphoid inhibitor of human lymphocyte DNA synthesis and mitosis in vitro. Nature (1969) 1.11
Thrombotic thrombocytopenic purpura. Recovery after splenectomy. Arch Intern Med (1966) 1.11
Musculoskeletal manifestations of amyloidosis. A review of 83 patients on haemodialysis for at least 10 years. J Bone Joint Surg Br (1991) 1.09
Reconstitution of EBV-specific T cell immunity in solid organ transplant recipients. J Immunol (1998) 1.09
Home dialysis in children and adolescents. Proc Eur Dial Transplant Assoc (1972) 1.09
Plasma hydroxyproline in renal osteodystrophy. Proc Eur Dial Transplant Assoc (1973) 1.04
Prospective study of human betaherpesviruses after renal transplantation: association of human herpesvirus 7 and cytomegalovirus co-infection with cytomegalovirus disease and increased rejection. Transplantation (2000) 1.03
Persistent hypophosphataemia and osteomalacia in dialysis patients not on oral phosphate-binders: Response to dihydrotachysterol therapy. Lancet (1976) 1.03
Observations on plasma magnesium levels in patients with uremic neuropathy under treatment by periodic hemodialysis. Neurology (1970) 1.03
Efficiency of scintillation counting of tritium labelled DNA-protein in the mixed leucocyte reaction in vitro. Nature (1966) 1.02
Phenytoin-induced pseudolymphoma. A report of a case and review of the literature. Br J Dermatol (1992) 1.00
Disorders of blood-lipids in renal disease. Lancet (1975) 0.99
Rejection encephalopathy. Proc Eur Dial Transplant Assoc (1981) 0.98
Renal physiology revisited: amiloride. Lancet (1986) 0.98
Vitamin A toxicity and hypercalcaemia in chronic renal failure. Br Med J (Clin Res Ed) (1981) 0.97
Parathyroid hormone as a causative factor of primary non-function in renal transplants. Br Med J (Clin Res Ed) (1988) 0.97
The effect of cyclosporin A on peripheral blood T cell subpopulations in renal allografts. Clin Exp Immunol (1982) 0.96
Acyclovir in hepatitis B antigen-positive chronic liver disease: inhibition of viral replication and transient renal impairment with iv bolus administration. J Antimicrob Chemother (1983) 0.96
Captopril-enhanced 99mTc DTPA scintigraphy in the detection of renal-artery stenosis. Nephrol Dial Transplant (1988) 0.96
Studies on long-term T-cell-mediated immunity to Epstein-BArr virus in immunosuppressed renal allograft recipients. Int J Cancer (1981) 0.96
Significance of high plasma renin activity in patients on maintenance haemodialysis therapy. Br Med J (1973) 0.96
Effect of fluvastatin on acute renal allograft rejection: a randomized multicenter trial. Kidney Int (2001) 0.96
Plasma renin activity and blood pressure in 89 patients receiving maintenance haemodialysis therapy. Br Med J (1972) 0.95
Gut hormones and glomerular hyperfiltration. Lancet (1984) 0.94
Acute tubular necrosis due to rhabdomyolysis and pancreatitis associated with Salmonella enteritidis food poisoning. Nephrol Dial Transplant (1993) 0.94
Hypophosphataemic osteomalacia after cadaveric renal transplantation. Lancet (1974) 0.93
Membranous glomerulonephritis and autoimmune thyroid disease. Clin Nephrol (1981) 0.92
Plasma immunoreactive melanotrophic hormones in patients on maintenance haemodialysis. Br Med J (1975) 0.92
Haemolytic-uraemic syndrome in recipients of bone marrow transplants not treated with cyclosporin A. Histopathology (1986) 0.91
Cytokine regulation of low-density lipoprotein receptor gene transcription in human mesangial cells. Nephrol Dial Transplant (1998) 0.90
The safety and efficacy of MMF in lupus nephritis: a pilot study. Lupus (2001) 0.90
Simvastatin therapy for hypercholesterolemic patients with nephrotic syndrome or significant proteinuria. Kidney Int (1993) 0.90
Rejection encephalopathy. An acute neurological syndrome complicating renal transplantation. J Neurol Sci (1982) 0.89
Plasma histamine in patients with chronic renal failure and nephrotic syndrome. J Clin Pathol (1991) 0.89
Plasma calcium and magnesium fractions in chronic-renal-failure patients on maintenance haemodialysis. Lancet (1973) 0.89
Three years' experience of continuous ambulatory peritoneal dialysis. Lancet (1981) 0.89